FDA Brief

Company record

Thrasio, LLC D/B/A ZymaDerm

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Thrasio, LLC D/B/A ZymaDerm.

Warning letters

  1. Thrasio, LLC D/B/A ZymaDerm

    FDA warned Thrasio/ZymaDerm that its ZymaDerm for Molluscum is an unapproved new drug marketed without FDA approval.

    High risk